Blueshift Asset Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-7,351
Closed -$866K – 721
2026
Q1
$866K Buy
+7,351
New +$1.03M 0.26% 87
2025
Q2
– Sell
-3,598
Closed -$458K – 576
2025
Q1
$458K Buy
+3,598
New +$554K 0.18% 175
2023
Q2
– Sell
-1,190
Closed -$200K – 453
2023
Q1
$200K Buy
+1,190
New +$212K 0.08% 313
2022
Q4
– Sell
-1,145
Closed -$214K – 585
2022
Q3
$214K Buy
+1,145
New +$241K 0.05% 500
2021
Q1
– Sell
-1,387
Closed -$266K – 1037
2020
Q4
$266K Buy
+1,387
New +$252K 0.03% 551

Other funds holding RGEN

Blueshift Asset Management's RGEN Position: Q2 2026 in Review

Blueshift Asset Management sold out of Repligen (RGEN) in Q2 2026, closing a stake of 7,351 shares — an estimated $866K sold.

Blueshift Asset Management first reported a position in RGEN in Q4 2020 and held it in 5 quarters. The position peaked at $866K in Q1 2026. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Blueshift Asset Management reported no remaining Repligen position as of Q2 2026 after selling out during the quarter.
  • Blueshift Asset Management sold 7,351 Repligen shares in Q2 2026, an estimated $866K.
  • Blueshift Asset Management first reported a position in Repligen in Q4 2020 and held it in 5 quarters.
  • Blueshift Asset Management's Repligen position peaked at $866K in Q1 2026.
  • 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Blueshift Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.